Overview

OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects

Status:
Completed

Trial end date:
2010-07-01

Target enrollment:

Participant gender:

Summary

The primary objectives are - to demonstrate that the treatment with OXN PR tablets is non-inferior to the treatment with OxyPR with regards to analgesic efficacy and locomotor function. - to demonstrate that subjects with moderate to severe OA pain taking oxycodone/naloxone prolonged release tablets have improvement in symptoms of constipation compared to subjects taking oxycodone prolonged release tablets alone

Phase:

Phase 3

Details

Lead Sponsor:

Mundipharma Research GmbH & Co KG

Treatments:

Naloxone
Oxycodone